Norihide Yokoi

Norihide Yokoi

Auto-generated profile, based on publicly available information

Norihide Yokoi

Laboratory of Animal Breeding and Genetics, Graduate School of Agriculture Kyoto University Kyoto Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
OOOkechi S. Oduori
Okechi S. Oduori
NMNaoya Murao
Naoya Murao
KSKenju Shimomura
Kenju Shimomura
HTHarumi Takahashi
Harumi Takahashi
QZQuan Zhang
Quan Zhang
SSSusumu Seino
Susumu Seino
By restoring glucose-regulated insulin secretion, glucagon-like peptide-1–based (GLP-1–based) therapies are becoming increasingly important in diabetes care. Normally, the incretins GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) jointly maintain normal blood glucose levels by stimulation of insulin secretion in pancreatic β cells. However, the reason why only GLP-1–based drugs are effective in improving insulin secretion after presentation of diabetes has not been resolved. ATP-sensitive K+ (KATP) channels play a crucial role in coupling the systemic metabolic status to β cell electrical activity for insulin secretion. Here, we have shown that persistent membrane depolarization of β cells due to genetic (β cell–specific Kcnj11–/– mice) or pharmacological (long-term exposure to sulfonylureas) inhibition of the KATP channel led to a switch from Gs to Gq in a major amplifying pathway of insulin secretion. The switch determined the relative insulinotropic effectiveness of GLP-1 and GIP, as GLP-1 can activate both Gq and Gs, while GIP only activates Gs. The findings were corroborated in other models of persistent depolarization: a spontaneous diabetic KK-Ay mouse and nondiabetic human and mouse β cells of pancreatic islets chronically treated with high glucose. Thus, a Gs/Gq signaling switch in β cells exposed to chronic hyperglycemia underlies the differential insulinotropic potential of incretins in diabetes.

1 January 2013 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
NYNorihide Yokoi
Norihide Yokoi
MHMasayuki Hoshino
Masayuki Hoshino
SHShihomi Hidaka
Shihomi Hidaka
EYEri Yoshida
Eri Yoshida
MBMasayuki Beppu
Masayuki Beppu
SSSusumu Seino
Susumu Seino
The Zucker fatty (ZF) rat harboring a missense mutation (fatty, fa) in the leptin receptor gene (Lepr) develops obesity without diabetes; Zucker diabetic fatty (ZDF) rats derived from the ZF strain exhibit obesity with diabetes and are widely used for research on type 2 diabetes (T2D). Here we establish a novel diabetic strain derived from normoglycemic ZF rats. In our ZF rat colony, we incidentally foundfa/fahomozygous male rats having reproductive ability, which is generally absent in these animals. During maintenance of this strain by matingfa/famales andfa/+heterozygous females, we further identifiedfa/famale rats exhibiting diabetes. We then performed selective breeding using thefa/famale rats that exhibited relatively high blood glucose levels at 10 weeks of age, resulting in establishment of a diabetic strain that we designated Hos:ZFDM-Leprfa(ZFDM). Thesefa/famale rats developed diabetes as early as 10 weeks of age, reaching 100% incidence by 21 weeks of age, while none of thefa/+male rats developed diabetes. The phenotypic characteristics of this diabetic strain are distinct from those of normoglycemic ZF rats. ZFDM rat strain having high reproductive efficiency should serve as a more useful animal model of T2D.

8 January 2021 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
GHGuirong Han
Guirong Han
HTHarumi Takahashi
Harumi Takahashi
NMNaoya Murao
Naoya Murao
GGGhupurjan Gheni
Ghupurjan Gheni
NYNorihide Yokoi
Norihide Yokoi
SSSusumu Seino
Susumu Seino
Aims/Introduction: Glutamine is the most abundant amino acid in the circulation. In this study, we investigated cell signaling in the amplification of insulin secretion by glutamine.Materials and Methods: Clonal pancreatic β‐cells MIN6‐K8, wild‐type B6 mouse islets, glutamate dehydrogenase (GDH) knockout clonal β‐cells (Glud1KOβCL), and glutamate‐oxaloacetate transaminase 1 (GOT1) knockout clonal β‐cells (Got1KOβCL) were studied. Insulin secretion from these cells and islets was examined under various conditions, and intracellular glutamine metabolism was assessed by metabolic flux analysis. Intracellular Ca2+ concentration ([Ca2+]i) was also measured.Results: Glutamine dose‐dependently amplified insulin secretion in the presence of high glucose in both MIN6‐K8 cells and Glud1KOβCL. Inhibition of glutaminases, the enzymes that convert glutamine to glutamate, dramatically reduced the glutamine‐amplifying effect on insulin secretion. A substantial amount of glutamate was produced from glutamine through direct conversion by glutaminases. Glutamine also increased [Ca2+]i at high glucose, which was abolished by inhibition of glutaminases. Glutamic acid dimethylester (dm‐Glu), a membrane permeable glutamate precursor that is converted to glutamate in cells, increased [Ca2+]i as well as induced insulin secretion at high glucose. These effects of glutamine and dm‐Glu were dependent on calcium influx. Glutamine also induced insulin secretion in clonal β‐cells MIN6‐m14, which otherwise exhibit no insulin secretory response to glucose.Conclusions: Glutamate converted from glutamine is an essential mediator that enhances calcium signaling in the glutamine‐amplifying effect on insulin secretion. Our data also suggest that glutamine exerts a permissive effect on glucose‐induced insulin secretion.

11 June 2019 in Proceedings of the Japan Academy, Series B
Verified
Journal Article
Open access
PDF file
HTHarumi Takahashi
Harumi Takahashi
NYNorihide Yokoi
Norihide Yokoi
SSSusumu Seino
Susumu Seino
L-Glutamate is one of the most abundant amino acids in the body and is a constituent of proteins and a substrate in metabolism. It is well known that glutamate serves as a primary excitatory neurotransmitter and a critical neuromodulator in the brain. Recent studies have shown that in addition to its pivotal role in neural functions, glutamate plays many important roles in a variety of cellular functions, including those as intracellular and extracellular signals. In pancreatic islets, glutamate is now known to be required for the normal regulation of insulin secretion, such as incretin-induced insulin secretion. In this review, we primarily discuss the physiological and pathophysiological roles of glutamate as intracellular and extracellular signals in the functions of pancreatic islets.

7 May 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
AKAyumi Kanno
Ayumi Kanno
Shunichiro AsaharaShunichiro Asahara
Shunichiro Asahara
AFAyuko Furubayashi
Ayuko Furubayashi
KMKatsuhisa Masuda
Katsuhisa Masuda
RYRisa Yoshitomi
Risa Yoshitomi
YKYoshiaki Kido
Yoshiaki Kido
EIF2AK4 , which encodes the amino acid deficiency–sensing protein GCN2, has been implicated as a susceptibility gene for type 2 diabetes in the Japanese population. However, the mechanism by which GCN2 affects glucose homeostasis is unclear. Here, we show that insulin secretion is reduced in individuals harboring the risk allele of EIF2AK4 and that maintenance of GCN2-deficient mice on a high-fat diet results in a loss of pancreatic β cell mass. Our data suggest that GCN2 senses amino acid deficiency in β cells and limits signaling by mechanistic target of rapamycin complex 1 to prevent β cell failure during the consumption of a high-fat diet.

28 June 2018 in Diabetes
Verified
Journal Article
Closed access
PDF file
MHMahira Hashim
Mahira Hashim
NYNorihide Yokoi
Norihide Yokoi
HTHarumi Takahashi
Harumi Takahashi
GGGhupurjan Gheni
Ghupurjan Gheni
OOOduori S. Okechi
Oduori S. Okechi
SSSusumu Seino
Susumu Seino
β-Cell–β-cell interactions are required for normal regulation of insulin secretion. We previously found that formation of spheroid clusters (called K20-SC) from MIN6-K20 clonal β-cells lacking incretin-induced insulin secretion (IIIS) under monolayer culture (called K20-MC) drastically induced incretin responsiveness. Here we investigated the mechanism by which an incretin-unresponsive state transforms to an incretin-responsive state using K20-SC as a model. Glutamate production by glucose through the malate-aspartate shuttle and cAMP signaling, both of which are critical for IIIS, were enhanced in K20-SC. SC formed from β-cells deficient for aspartate aminotransferase 1, a critical enzyme in the malate-aspartate shuttle, exhibited reduced IIIS. Expression of the sodium-coupled neutral amino acid transporter 5 (SNAT5), which is involved in glutamine transport, was downregulated in K20-SC and pancreatic islets of normal mice but was upregulated in K20-MC and islets of rodent models of obesity and diabetes, both of which exhibit impaired IIIS. Inhibition of SNAT5 significantly increased cellular glutamate content and improved IIIS in islets of these models and in K20-MC. These results suggest that suppression of SNAT5 activity, which results in increased glutamate production, and enhancement of cAMP signaling endows incretin-unresponsive β-cells with incretin responsiveness.